Bioventix PLC (AIM:BVXP)

London · Delayed Price · Currency is GBP · Price in GBX

1,425.00

+25.00 (1.79%)

At close: Mar 25, 2026

Revenue by Geography

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012
United Kingdom Revenue	798.66K	405.46K
United Kingdom Revenue Growth	96.98%	-57.85%
European Union Revenue	1.64M	1.51M
European Union Revenue Growth	8.81%	-6.02%
Rest Of The World Revenue	10.68M	11.69M
Rest Of The World Revenue Growth	-8.70%	14.08%
Revenue (Total)	13.12M	13.61M
Revenue (Total) Growth	-3.61%	6.17%

Revenue

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012
Product Revenue & R&D Income	4.16M	4.46M
Product Revenue & R&D Income Growth	-6.63%	5.35%
Royalty & Licence Fee Income	8.95M	9.15M
Royalty & Licence Fee Income Growth	-2.14%	6.57%
Revenue (Total)	13.12M	13.61M
Revenue (Total) Growth	-3.61%	6.17%

Updated Nov 8, 2024. Data Source: Fiscal.ai.